Pretreatment parameters associated with hemorrhagic transformation among successfully recanalized medium vessel occlusions

J Neurol. 2024 Apr;271(4):1901-1909. doi: 10.1007/s00415-023-12149-4. Epub 2023 Dec 15.

Abstract

Although pretreatment radiographic biomarkers are well established for hemorrhagic transformation (HT) following successful mechanical thrombectomy (MT) in large vessel occlusion (LVO) strokes, they are yet to be explored for medium vessel occlusion (MeVO) acute ischemic strokes. We aim to investigate pretreatment imaging biomarkers representative of collateral status, namely the hypoperfusion intensity ratio (HIR) and cerebral blood volume (CBV) index, and their association with HT in successfully recanalized MeVOs. A prospectively collected registry of acute ischemic stroke patients with MeVOs successfully recanalized with MT between 2019 and 2023 was retrospectively reviewed. A multivariate logistic regression for HT of any subtype was derived by combining significant univariate predictors into a forward stepwise regression with minimization of Akaike information criterion. Of 60 MeVO patients successfully recanalized with MT, HT occurred in 28.3% of patients. Independent factors for HT included: diabetes mellitus history (p = 0.0005), CBV index (p = 0.0071), and proximal versus distal occlusion location (p = 0.0062). A multivariate model with these factors had strong diagnostic performance for predicting HT (area under curve [AUC] 0.93, p < 0.001). Lower CBV indexes, distal occlusion location, and diabetes history are significantly associated with HT in MeVOs successfully recanalized with MT. Of note, HIR was not found to be significantly associated with HT.

Keywords: Computed tomography; Hemorrhage; Ischemic stroke; Medium vessel occlusion; Neuroimaging; Thrombectomy.

MeSH terms

  • Arterial Occlusive Diseases* / complications
  • Biomarkers
  • Brain Ischemia* / complications
  • Humans
  • Ischemic Stroke* / complications
  • Retrospective Studies
  • Stroke* / complications
  • Thrombectomy
  • Treatment Outcome

Substances

  • Biomarkers